Free Daily Podcast Summary
PsychRounds: The Psychiatry Podcast: Daily Summaries Delivered
by Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller
Welcome to Psych Rounds, the podcast tailored for psychiatry residents and students. Join us, three psychiatric resident physicians, as we delve into quick insights, interviews, and practical tips essential for educational practice. Subscribe for a straightforward yet informal approach to psychiatric knowledge. Contact us: psychroundspodcast@gmail.com Instagram: https://www.instagram.com/psychrounds/
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 2 days ago19 min
Modafinil (Provigil)
Welcome back! Today, we are looking at Modafinil and it's nuanced use in psychiatry.References:Provigil (modafinil) [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA, Inc. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/drugsatfdadocs/label/2015/020717s037s038lbl.pdfSchwartz JR. Modafinil in the treatment of excessive sleepiness. Drug Des Devel Ther. 2009;2:71–85.Kaplan S, Goehring EL Jr, Engel T, et al. Cardiovascular outcomes associated with modafinil in patients with obstructive sleep apnea. Pharmacoepidemiol Drug Saf. 2018;27(11):1182–1190. doi:10.1002/pds.4642Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727–738. doi:10.1016/S2215-0366(18)30269-4Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry. 2013;74(11):1101–1107. doi:10.4088/JCP.13r08560Bahji A, Mesbah-Oskui L. Comparative efficacy and safety of stimulant-type medications for depression: a systematic review and network meta-analysis. J Affect Disord. 2021;292:416–423. doi:10.1016/j.jad.2021.05.119Nunez NA, Singh B, Jorgensen A, et al. Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: a meta-analysis of randomized controlled trials. Bipolar Disord. 2020;22(2):109–120. doi:10.1111/bdi.12859
- 2 weeks ago16 min
Naltrexone: Use in Psychiatry
Welcome Back! Today we are discussing the medication Naltrexone and its uses in psychiatry. References: https://www.ncbi.nlm.nih.gov/books/NBK534811/https://pubmed.ncbi.nlm.nih.gov/24825644/https://pubmed.ncbi.nlm.nih.gov/26798982/https://www.nejm.org/doi/full/10.1056/NEJMct0801733https://pubmed.ncbi.nlm.nih.gov/26798982/
- May 6, 202622 min
Placebo Effect and Response in Psychiatry
Welcome back! Today, we will be discussing the placebo effect.References:https://pubmed.ncbi.nlm.nih.gov/16503356/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003660/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556377/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714297/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694178/https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/2018/11/19/understanding-placebo
- Apr 8, 202617 min
Amantadine (Symmetrel)
Welcome back! Today we are talking all about Amantadine, and it's uses in psychiatry.
- Mar 21, 202617 min
VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)
Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References: https://pubmed.ncbi.nlm.nih.gov/41626799/https://www.ncbi.nlm.nih.gov/books/NBK548187/https://pubmed.ncbi.nlm.nih.gov/41626799/
- Feb 25, 202655 min
A DSM Conversation with Dr. Allen Frances
We are back with another special guest episode! Please welcome Dr. Allen Frances, who was intricately involved in the formation of both the DSM III and DSM IV, the latter of which he served as chair.https://x.com/AllenFrancesMDhttps://www.amazon.com/stores/author/B001HO76FUhttps://www.psychiatrictimes.com/authors/allen-frances-md
- Jan 28, 202615 min
Topiramate (Topamax)
Welcome back! Today we will be doing a brief episode on Topiramate [Topamax], and its clinical uses in psychiatry.References:https://pubmed.ncbi.nlm.nih.gov/21438989/https://pubmed.ncbi.nlm.nih.gov/18774432/https://pubmed.ncbi.nlm.nih.gov/25899459/https://pmc.ncbi.nlm.nih.gov/articles/PMC1088011/https://pmc.ncbi.nlm.nih.gov/articles/PMC2671954/https://pubmed.ncbi.nlm.nih.gov/38706338/https://pubmed.ncbi.nlm.nih.gov/20207521/
- Jan 14, 202654 min
What Makes Something a Psychiatric Illness? Featuring Dr. Mark Ruffalo, MSW, DPsa
Welcome back, today we are discussing a deceptively difficult topic: What makes something a psychiatric illness? We are joined by our guest Dr. Mark Ruffalo. He is a psychotherapist in private practice in Tampa, FL, and who also serves as Assistant Professor of Psychiatry at the University of Central Florida College of Medicine as well an Adjunct Assistant Professor of Psychiatry at Tufts University School of Medicine. Dr. Ruffalo's Website: https://www.drruffalo.com/Dr. Ruffalo's LinkedIn: https://www.linkedin.com/in/mark-l-ruffalo-71929063PRISM: https://www.psychiatrictimes.com/view/use-of-the-prism-diagnostic-instrument-in-clinical-practicePRISM Writing Contest: https://www.psychiatrictimes.com/view/prism-writing-contest-more-on-this-new-diagnostic-tool-from-mark-ruffalo-msw-dpsa
About PsychRounds: The Psychiatry Podcast
Welcome to Psych Rounds, the podcast tailored for psychiatry residents and students. Join us, three psychiatric resident physicians, as we delve into quick insights, interviews, and practical tips essential for educational practice. Subscribe for a straightforward yet informal approach to psychiatric knowledge. Contact us: psychroundspodcast@gmail.com Instagram: https://www.instagram.com/psychrounds/
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from PsychRounds: The Psychiatry Podcast in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's PsychRounds: The Psychiatry Podcast daily summary?
It's a free AI-powered email that summarizes new episodes of PsychRounds: The Psychiatry Podcast as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the PsychRounds: The Psychiatry Podcast podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official PsychRounds: The Psychiatry Podcast product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does PsychRounds: The Psychiatry Podcast release new episodes?
PsychRounds: The Psychiatry Podcast publishes biweekly. Our AI generates a summary within hours of each new episode.
What topics does PsychRounds: The Psychiatry Podcast cover?
PsychRounds: The Psychiatry Podcast covers topics including Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting PsychRounds: The Psychiatry Podcast summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.